Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Orthox, a UK-based developer of medical implants for repairing orthopaedic injuries such as damaged knee articular cartilage, has added $4.3m to its series A round for a $12.5m close. The round was led by Parkwalk Advisors, the fund management arm of commercialisation firm IP Group, as well as Oxford Technology and Innovations EIS Fund, Perivoli…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
